Meeder Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,209
| Closed | -$147K | – | 2514 |
|
|
2019
Q3 | $147K | Buy |
6,209
+1,290
| +26% | +$30.5K | 0.01% | 690 |
|
|
2019
Q2 | $147K | Hold |
4,919
| – | – | 0.01% | 655 |
|
|
2019
Q1 | $111K | Sell |
4,919
-392
| -7% | -$8.85K | 0.01% | 679 |
|
|
2018
Q4 | $96K | Buy |
5,311
+2,049
| +63% | +$37K | 0.01% | 647 |
|
|
2018
Q3 | $60K | Buy |
+3,262
| New | +$60K | ﹤0.01% | 749 |
|
|
2018
Q2 | – | Sell |
-237
| Closed | -$1K | – | 1749 |
|
|
2018
Q1 | $1K | Buy |
+237
| New | +$1K | ﹤0.01% | 1519 |
|
|
2017
Q2 | – | Sell |
-79
| Closed | -$2K | – | 2006 |
|
|
2017
Q1 | $2K | Buy |
+79
| New | +$2K | ﹤0.01% | 1448 |
|